On NoticeOn Notice
← Bills

Therapeutic Goods (Charges) Amendment Bill 2026

Unknown
18 November 2026 · 1 day agoExplanatory Memorandum →

Summary

The Therapeutic Goods Administration currently charges fees to companies that want to register medicines, medical devices, and other health products in Australia. This amendment changes how those fees work — it updates the charges that companies pay when they submit products for approval, renewal, or other regulatory processes under the Therapeutic Goods Act 1989. The changes matter because they affect the cost of bringing new medicines and devices to Australian patients; higher fees might slow down approvals or increase medicine prices, while lower fees could speed up access but reduce funding for safety checks.

Bill Progress

Senate

First Reading

Second Reading

Committee of the Whole

Third Reading

House of Representatives

First Reading

Second Reading

Consideration in Detail

Third Reading

Royal Assent

Royal Assent